DOCSLIB.ORG

List of Selected Papers for Poster Presentation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Selected Papers for Poster Presentation 70TH INDIAN PHARMACEUTICAL CONGRESS LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1780 CHANAM MELODY DEVI A-411 DEVELOPMENT AND EVALUATION OF BRINZOLAMIDE LOADED SOLID LIPID NANOPARTICLES 939 ALISHA PARIDA F-110 Phytochemical and Physicochemical standardization of plant Cissus quadrangularis A SURVEY ON AWARENESS AND PROBLEMS MENSTRUATION AMONG FEMALE STUDENTS OF A. 302 GADAMSETTY. JAYA ALEKHYA SITA D-32 M.REDDY COLLEGE FORMULATION AND EVALUATION OF PHYTOSOME LOADED DRUG DELIVERY OF GINGEROL 58 RUDRA PRATAP SINGH 1A-1 A-22 FOR THE TREATMENT OF RESPIRATORY INFECTION FORMULATION AND OPTIMIZATION OF GASTRORETENTIVE BIOADHESIVE FLOATING TABLETS 181 DHARMAJIT PATTANAYAK 1A-10 A-148 OF ORAL HYPOGYSEMIC AGENTS. 1236 DILRAJ E 1A-100 A-594 CUMINCOMPARATIVE AND RESIDRONATE EVALUATION LOADED OF TABLETS CHITOSAN FORMULATED MICROPARTICLES BY ARTOCARPUS FOR TREATMENT HETEROPHYLLUS, OF 1241 MOHAMMAD RASHID 1A-101 A-597 OSTEOPOROSISFLAX SEED AND GUM ACACIA AS NATURAL GUM EXPLORING MALTODEXTRIN AS TASTE MASKING AGENT FOR OSELTAMIVIR PHOSPHATE- 1252 ATIN KALRA, INDU PAL KAUR, PRITISH BHAT 1A-102 A-561 MOLECULAR MODELING AND FORMULATION DEVELOPMENT 1262 ASHA ASHOK NEGINHAL 1A-103 A-564 “PREPARATION AND EVALUATION OF PULSINCAP OF PANTOPRAZOLE SODIUM” VARIOUS APPROACHES TO IMPROVE THE DISINTEGRATION AND DISSOLUTION OF GELATIN 1272 DEEPA N AMMINBAVI 1A-104 A-566 CAPSULE 1279 ATUL ADHIKARI 1A-105 A-567 ESTABLISHMENT OF IN-VITRO IN-VIVO DATA FROM GASTRO-RETENTIVE MATRIX TABLETS DESIGN AND DEVELOPMENT OF EXTENDED RELEASE TABLET CONTAINING VERAPAMIL HCL TO 1286 PANKAJ KOTVAL 1A-106 A-569 OVERCOME THE HYDRO ALCOHOLIC MEDIA INDUCED DOSE DUMPING 1318 ATUL 1A-107 A-547 PRONIOSOMES: A NOVEL VESICULAR DRUG DELIVERY SYSTEM PREPARATION AND INVITRO EVALUATION OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR 1326 DEEPIKA SHARMA 1A-108 A-551 SITAGLIPTIN BY ETHANOL INJECTION METHOD FAST DISSOLVING FILMS OF ONDANSETRON HYDROCHLORIDE: DEVELOPMENT AND 1334 MANIMA MAHARJAN 1A-109 A-555 OPTIMIZATION BY DESIGN EXPERT STUDY OF FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLET OF 182 SIDHARTHA SANKAR PADHY 1A-11 A-149 BISOPROLOL 6 SURADA NOOKA RAJU 1A-110 A-2 FORMULATION AND EVALUATION OF SR TABLETS OF GLICLAZIDE FORMULATION AND DESIGN OF MICROPARTICULATE DRUG DELIVERY SYSTEM OF LAMIVUDINE 1341 P UMA HARI PRIYA 1A-111 A-557 BY CHITOSAN AS NATURAL POLYMER DEVELOPMENT AND INVESTIGATION OF CONTROLLED RELEASE POTENTIAL OF 1345 RAUT SUSHIL YADAORAO 1A-112 A-559 NANOCOMPOSITE CLAY AND BIOPOLYMER HYBRID MICROBEADS DESIGN AND DEVELOPMENT OF DICLOFENAC BILAYERD TABLTES BY USING NATURAL GUM AS 1364 DHULIPALLA NAGA HARISH 1A-113 A-530 A KEY EXCIPENT FORMULATION DEVELOPMENT AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS 1377 V D SUNDAR 1A-114 A-531 OF RANOLAZINE 1390 DEBANKINI DASGUPTA 1A-115 A-534 FORMULATION AND EVALUATION OF RANITIDINE AND ALOEVERA FLOATING TABLET SOLID DISPERSIONS OF NAPROXEN WITH BINARY HYDROTROPIC BLENDS FOR DISSOLUTION 1402 POONAM CHAUDHARY 1A-116 A-512 RATE ENHANCEMENT DESIGN AND CHARACTERIZATION OF SITAGLIPTIN LOADED NANOSTRUCTURED LIPID 1437 REVATHI SUNDARAMOORTHY 1A-117 A-521 CARRIERS BY SOLVENT EVAPORATION DEVELOPMENT AND OPTIMIZATION OF AN ANTIDIABETIC MUCOADHESIVE EXTENDED RELEASE 1442 S. SATYA HARSHA 1A-118 A-523 TABLETS BY QBD TECHNOLOGY 70TH INDIAN PHARMACEUTICAL CONGRESS LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF ALGINATE MATRIX TABLET CONTAINING METOPROLOL 1450 B.DIVYA SHALINI 1A-119 A-527 SUCCINATE 185 SUPRITHA REDDY 1A-12 A-151 FORMULATION AND EVALUATION OF NICARDIPINE SUSTAINED RELEASE TABLETS 1455 A Ramu 1A-120 A-495 Formulation and Evaluation of Sustained Release Matrix Tablets of Dolutegravir Sodium DESIGN AND CHARACTERIZATION OF CONTROLLED RELEASE MATRIX TABLETS OF GLIPIZIDE 1465 P.N.MALLIKARJUN 1A-121 A-501 USING AVENA SATIVA GUM DESIGN AND CHARACTERIZATION OF CONTROLLED RELEASE MATRIX TABLETS OF GLIPIZIDE 1468 P.N.MALLIKARJUN 1A-122 A-502 USING AVENA SATIVA GUM 1487 NURUL AMIN 1A-123 A-508 FORMULATION AND CHARACTERIZATION OF MULTIPLE EMULSION OF PARACETAMOL DEVELOPMENT AND IN VITRO EVALUATION OF LIQUISOLID COMPACTS OF 1501 AKANKSHA 1A-124 A-474 LORNOXICAM FORMULATION AND EVALUATION OF FLOATING MICROBALOONS CONTAINING ZIPRASIDONE 1508 G.UMA RANI 1A-125 A-476 HYDROCHLORIDE FOR GASTRIC RETENTION FORMULATION AND EVALUATION OF DIPHENHYDRAMINE HCL ORALLY DISINTEGRATING 1517 CHARUMATHY A 1A-126 A-479 TABLETS 1519 DEEPIKA RAINA 1A-127 A-481 FORMULATION AND EVALUATION OF DULOXETINE LOADED BIO- NANOSUSPENSION 1542 AKANKSHA 1A-128 A-489 DEVELOPMENT AND OPTIMIZATION OF PRAVASTATIN NANOPARTICLES 1577 PRAVIN PANDURANG HONMANE 1A-129 A-466 FORMULATION AND CHARACTERIZATION OF ATORVASTATIN NANOCYSTAL TABLET FORMULATION AND CHARACTERIZATION OF KETACONAZOLE MICROSPONGES USING 213 PARIMALAKRISHNAN S 1A-13 A-60 VARIOUS POLYMERS FOR TOPICAL DRUG DELIVERY SYSTEM ENHANCEMENT OF SOUBILITY AND PERMEABILITY OF CEFPODOXIME PROXETIL BY SELF 1592 V.S.HARINI 1A-130 A-470 MICROEMULSIFYING DRUG DELIVERY SYSTEM FORMULATION AND EVALUATION OF OIL ENTRAPPED GASTRORETENTIVE FLOATING BEADS 1626 MAHESH KUMAR KATARIA 1A-131 A-451 OF METOPROLOL SUCCINATE FORMULATION AND EVALUATION OF FLOATING PULSATILE DRUG DELIVERY SYSTEM OF 1634 RAJAT PRAJAPAT 1A-132 A-456 LAFUTIDINE STATISTICAL DESIGN, OPTIMIZATION AND EVALUATION OF AN ORAL IN SITU GEL OF AN 1666 SURESH CHAPAGAIN 1A-133 A-430 ANTIDIABETIC DRUG FOR SUSTAINED RELEASE 1668 AISHWARYA C. PATIL 1A-134 A-432 “STUDIES OF SOLUBILITY ENHANCEMENT OF GEFITINIB” 1705 SHIVAM VASHIST 1A-135 A-418 NANOMEDICINE FOR CANCER THERAPY "DEVELOPMENT FORMULATION AND EVALUATION OF CONTROL RELEASE TABLET OF 1726 CHANDRA KUMAR SHARMA 1A-136 A-422 TRAMADOL USING NATURAL AND SYNTHETIC POLYMER" FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF LINAGLIPTIN BY 1738 J NAGA VENKATA PAVAN 1A-137 A-427 DIRECT COMPRESSION TECHNIQUES DEVELOPMENT OF PRESSED TABLET OF FELODIPINE AND EFFECT OF DIFFERENT POLYMER 1778 SHWETA SINGH CHAUHAN 1A-138 A-409 VISCOSITY AND COMBINATION ON RELEASE PROFILE IMPROVING SOLUBILIZATION AND BIOAVAILABILITY ENHANCEMENT OF LIPOPHILLIC DRUG 1779 GIRISH CHANDRA SONI 1A-139 A-410 REPAGLINIDE USING SELF EMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) TECHNIQUE. Design and in vitro evaluation of gastro retentive oral matrix tablet formulations of Ketorolac 237 MANISH KUMAR THIMMARAJU 1A-14 A-64 Tromethamine 1782 B.Sai Rohith 1A-140 A-412 Optimization of Cinnarizine Buccal Patches & In-Vitro Evaluation by using QBD 70TH INDIAN PHARMACEUTICAL CONGRESS LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1786 AYUSH 1A-141 A-413 Formulation and Evaluation of Medicated Chewing Gum for Tooth Decay. 1789 D.SRINIVAS 1A-142 A-415 D.Srinivas DEVELOPMENT AND CHARACTERIZATION OF GASTRORETENTIVE HIGHDENSITY PELLETS 1799 AMIT SHARMA 1A-143 A-417 LODGED WITH ZERO VALENT IRON NANOPARTICLES IMPROVING SOLUBILIZATION AND BIOAVAILABILITY ENHANCEMENT OF LIPOPHILLIC DRUG 1820 GIRISH CHANDRA SONI 1A-148 A-396 REPAGLINIDE USING SELF EMULSIFYING DRUG DELIVERY (SNEDDS) TECHNIQUE FORMULATION AND EVALUATION OF SUMATRIPTAN ORAL DISINTEGRATING TABLETS BY 241 T.SNEHAREDDY 1A-15 A-65 USING HIBISCUS ROSA SINESIS DEVELOPMENT OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM FOR ANTIHYPERTENSIVE 1833 SREENIVASA REDDY N 1A-151 A-400 DRUGS: THEIR IN VITRO & IN VIVO EVALUATION. SYSTEMATIC FORMULATION AND DEVELOPMENT OF EMTRICITABANE FLOATING 1868 ANNAMMADEVI G S 1A-153 A-384 MICROSPHERES 1937 PRAGYA . SHARMA 1A-159 A-376 BETA-GALACTOSIDASE BASED GELATIN MICROSPHERES FOR LACTOSE INTOLERANCE CHITOSAN-GLICLAZIDE MUCOADHESIVE MICROPARTICLES: PREPARATION AND INVITRO AND 249 P. VEERA LAKSHMI 1A-16 A-67 INVIVO EVALUATION FORMULATION AND EVALUATION OF METFORMIN HCL MATRIX TABLET USING NATURAL 1948 TRIDEEP SAIKIA 1A-160 A-379 POLYMER FUROSEMIDE-LOADED ALGINATE MICROSPHERES PREPARED BY IONIC CROSS-LINKING 1976 SRIGADE YASHASWINI 1A-161 A-361 TECHNIQUE 1986 VHORA TEJAS JITENDRA 1A-162 A-366 pH Sensitive Colon Specific Drug Delivery System DEVOLOPEMENT AND EVALUTION OF OPTIMISED FORMULATION OF LORAZEPAM MATRIX 1991 SRIDHAR REDDY 1A-163 A-367 TABLET 2000 SWATI B KAVADE 1A-164 A-368 “REVIEW ON ORAL DISINTEGRATED TABLET” FUROSEMIDE-LOADED ALGINATE MICROSPHERES PREPARED BY IONIC CROSS-LINKING 2005 SRIGADHE YASHASWINI 1A-165 A-347 TECHNIQUE 2015 MONA 1A-166 A-350 FORMULATION AND EVALUATION OF ORODIAPERSIBLE TABLETS OF TRANDOLAPRIL PREPARATION AND EVALUATION OF TOLCAPONE LOADED ALGINATE MICROSPHERES FOR 2016 SARITHA 1A-167 A-351 CONTROLLED RELEASE Formulation and Evaluation of pH Sensitive Superporous Hydrogels of Glipizide using Design of 2103 M P GOWRAV 1A-168 A-329 Experimentation 2029 SWATI B.KAWADE 1A-169 A-353 REVIEW ON ORAL DISINTEGRATED TABLET 5 KARRI SRINIVASA REDDY 1A-17 A-6 FORMULATION AND OPTIMIZATION OF VALSARTAN SUSTAINED RELEASE FLOATING TABLETS KINETIC MODELLING OF DRUG RELEASE FROM DILTIAZEM MATRIX TABLETS BASED ON 2043 DEEPAK TAYAL 1A-170 A-355 NATURE OF MATRIX FORMING SYNTHETIC AND NATURAL POLYMERS FORMULATION & EVALUATION OF KETOROLAC TROMETHAMINE FAST DISSOLVING TABLETS BY 2051 M.VAISHNAVI BAI 1A-171 A-330 USING NATURAL GUM AS KEY EXCIPIENT KINETIC MODELLING OF DRUG RELEASE FROM DILTIAZEM MATRIX TABLETS BASED ON 2054 DEEPAK
Load more

Recommended publications
  • Conceptualizing Multiple Drug Use in Patients with Comorbidity and Multimorbidity: Proposal for Standard Definitions Beyond the Term Polypharmacy Umesh T
    Journal of Clinical Epidemiology 106 (2019) 98e107 ORIGINAL ARTICLE Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy Umesh T. Kadama,d,*, Isobel Robertsb, Simon Whitec, Ruth Bednallb, Kamlesh Khuntid, Peter M. Nilssone, Claire A. Lawsond aDepartment of Health Sciences, University of Leicester, Leicester LE1 7RH, UK bPharmacy Directorate, University Hospitals of North Staffordshire, Stoke-on-Trent ST4 6QG, UK cSchool of Pharmacy, Keele University, Keele ST5 5BG, UK dDiabetes Research Centre, University of Leicester, Leicester LE5 4PW, UK eDepartment of Clinical Sciences, Lund University, Malmo€ S-205 02, Sweden Accepted 24 October 2018; Published online 29 October 2018 Abstract With older and aging populations, patients experience multiple chronic diseases at the same time. Individual chronic disease guidelines often recommend pharmacological therapies as a key intervention, resulting in patients being prescribed multiple regular medications for their different diseases. Although the term ‘‘polypharmacy’’ has been applied to the use of multiple medications, there is no consistent definition, and this term is now being used all inclusively. To improve both scientific rigor and optimal patient care, it is crucial that a stan- dard terminology is used, which reclassifies the term ‘‘polypharmacy’’ into distinct phenotypes relating to the index chronic disease, addi- tional conditions to the index (comorbidity), or the experience of multiple chronic
    [Show full text]
  • Synthetic and Biological Investigations Into Hypoxia-Activated Anti-Tumour Codrugs
    University of Wollongong Research Online University of Wollongong Thesis Collection 1954-2016 University of Wollongong Thesis Collections 2015 Synthetic and biological investigations into hypoxia-activated anti-tumour codrugs Nicholas Kirk University of Wollongong Follow this and additional works at: https://ro.uow.edu.au/theses University of Wollongong Copyright Warning You may print or download ONE copy of this document for the purpose of your own research or study. The University does not authorise you to copy, communicate or otherwise make available electronically to any other person any copyright material contained on this site. You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act 1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised, without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court may impose penalties and award damages in relation to offences and infringements relating to copyright material. Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the conversion of material into digital or electronic form. Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily represent the views of the University of Wollongong. Recommended Citation Kirk, Nicholas, Synthetic and biological investigations into hypoxia-activated anti-tumour codrugs, Doctor of Philosophy thesis, School of Chemistry, University of Wollongong, 2015.
    [Show full text]
  • SYNTHESIS and STABILITY STUDIES of PRODRUGS and CODRUGS of NALTREXONE and 6-Β-NALTREXOL Joshua A
    University of Kentucky UKnowledge Theses and Dissertations--Pharmacy College of Pharmacy 2013 SYNTHESIS AND STABILITY STUDIES OF PRODRUGS AND CODRUGS OF NALTREXONE AND 6-β-NALTREXOL Joshua A. Eldridge University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Recommended Citation Eldridge, Joshua A., "SYNTHESIS AND STABILITY STUDIES OF PRODRUGS AND CODRUGS OF NALTREXONE AND 6-β- NALTREXOL" (2013). Theses and Dissertations--Pharmacy. 16. https://uknowledge.uky.edu/pharmacy_etds/16 This Doctoral Dissertation is brought to you for free and open access by the College of Pharmacy at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Pharmacy by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained and attached hereto needed written permission statements(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine). I hereby grant to The nivU ersity of Kentucky and its agents the non-exclusive license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. I agree that the document mentioned above may be made available immediately for worldwide access unless a preapproved embargo applies.
    [Show full text]
  • CPC Scheme Between 2015.05 and 2015.07
    2015.07 Compilation of Changes to the CPC Scheme Between 2015.05 and 2015.07 Presentation Details Entries for new symbols and headings: Black text in italics Entries for existing symbols and headings —text insertions: Green text in italics with yellow background —text deletions: Red strikethrough text with grey background Entries for deleted symbols and headings: Black strikethrough text • In cases when the originating project cannot be found, "N/A" is given for the Project information (e.g. the change could be due to an Editorial Correction). • Projects ending in "-F" indicate finalisation after reclassification was completed. Project: N/A (A01B) U A01B 3/00 Ploughs with fixed plough-shares U A01B 3/04 · Animal-drawn ploughs A01B 3/06 · · without alternating possibility, i.e. incapable of making an adjacent furrow on return journey, {i.e. conventional ploughing} U A01B 3/50 · Self-propelled ploughs U A01B 3/52 · · with three or more wheels, or endless tracks U A01B 3/56 · · · Alternating ploughs; {Balance ploughs} U A01B 3/64 · Cable ploughs; Indicating or signalling devices for cable plough systems {(vehicles towed by cable B60D)} U A01B 3/68 · · Cable systems with one or two engines; {e.g. electrically-driven or with diesel generating set} U A01B 5/00 Ploughs with rolling non-driven tools, e.g. discs (with rotary driven tools A01B 9/00) U A01B 5/04 · drawn by tractors A01B 5/06 · · without alternating possibility, {e.g. with rotary counters provided with scrapers} U A01B 13/00 Ploughs or like machines for special purposes (for drainage E02B 11/02); {Ditch diggers, trench ploughs, forestry ploughs, ploughs for land or marsh reclamation (machines for aerating meadows A01B 45/02 ; making furrows A01C 5/00 ; dredging machines in general E02F)} A01B 13/02 · for making or working ridges, e.g.
    [Show full text]
  • UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Consider The Pill: Pharmacentric Readings of Post-WWII American Literature Permalink https://escholarship.org/uc/item/4q62090h Author Farinholt, Rhett Publication Date 2019 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA SAN DIEGO Consider The Pill: Pharmacentric Readings of Post-WWII American Literature A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Literature by Rhett William Farinholt Committee in charge: Professor Michael Davidson, Co-Chair Professor Meg Wesling, Co-Chair Professor Brian Goldfarb Professor Lisa Lampert-Weissig Professor Wm. Arctander O’Brien 2019 Copyright Rhett William Farinholt, 2019 All rights reserved. The Dissertation of Rhett William Farinholt is approved, and it is acceptable in quality and form for publication on microfilm and electronically: _____________________________________________________________ _____________________________________________________________ _____________________________________________________________ _____________________________________________________________ Co-chair _____________________________________________________________ Co-chair University of California San Diego 2019 iii DEDICATION To my parents, Neal and Melanie, without whose love and inspiration, I would not have been in a position to pursue this project. To my wife, Gina, without whose support and
    [Show full text]
  • Opioid Codrugs for Pain Management
    University of Kentucky UKnowledge Theses and Dissertations--Chemistry Chemistry 2011 OPIOID CODRUGS FOR PAIN MANAGEMENT Ujjwal Chakraborty University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Chakraborty, Ujjwal, "OPIOID CODRUGS FOR PAIN MANAGEMENT" (2011). Theses and Dissertations-- Chemistry. 2. https://uknowledge.uky.edu/chemistry_etds/2 This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained and attached hereto needed written permission statements(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine). I hereby grant to The University of Kentucky and its agents the non-exclusive license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. I agree that the document mentioned above may be made available immediately for worldwide access unless a preapproved embargo applies. I retain all other ownership rights to the copyright of my work. I also retain the right to use in future works (such as articles or books) all or part of my work.
    [Show full text]
  • Opioid-Cannabinoid Codrugs with Enhanced Analgesic and Pharmacokinetic Profile
    University of Kentucky UKnowledge University of Kentucky Doctoral Dissertations Graduate School 2010 OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE Harpreet Kaur Dhooper University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Dhooper, Harpreet Kaur, "OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE" (2010). University of Kentucky Doctoral Dissertations. 98. https://uknowledge.uky.edu/gradschool_diss/98 This Dissertation is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted for inclusion in University of Kentucky Doctoral Dissertations by an authorized administrator of UKnowledge. For more information, please contact [email protected]. ABSTRACT OF DISSERTATION Harpreet Kaur Dhooper College of Arts & Sciences University of Kentucky 2010 OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE _________________________________________ ABSTRACT OF DISSERTATION _________________________________________ A dissertation submitted in partial fulfillment of the requirement for the degree of Doctor of Philosophy in the College of Arts & Sciences at the University of Kentucky By Harpreet Kaur Dhooper Lexington, Kentucky Director: Dr. Peter A. Crooks, Professor of Pharmaceutical Sciences Lexington, Kentucky 2010 Copyright © Harpreet Dhooper 2010 ABSTRACT OF DISSERTATION OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC
    [Show full text]
  • CPC Scheme Between 2017.05 and 2017.08
    2017.08 Compilation of Changes to the CPC Scheme Between 2017.05 and 2017.08 Presentation Details Entries for new symbols and headings: Black text in italics Entries for existing symbols and headings —text insertions: Green text in italics with yellow background —text deletions: Red strikethrough text with grey background Entries for deleted symbols and headings: Black strikethrough text • Entries arranged by project. Duplicate entries may appear where multiple projects impact the same symbol • In cases when the originating project cannot be found, "N/A" is given for the Project information (e.g. the change could be due to an Editorial Correction). • Projects ending in "-F" indicate finalisation after reclassification was completed. Project: MP0128 (C21D) M C21D 1/00 General methods or devices for heat treatmentstreatment, e.g. annealing, hardening, quenching, tempering or tempering(furnaces in general F27; electric heating per se H05B) M C21D 1/55 · Hardenability tests, e.g. end-quench tests (investigating chemical or physical properties of materials in general G01N) U C21D 1/62 · Quenching devices U C21D 1/63 · · for bath quenching M C21D 1/64 · · · with circulating liquids (in general F28D) M C21D 1/74 · Methods of treatment in inert gas, controlled atmosphere, vacuum, or pulverulent material (production of gases C01, C10) M C21D 1/82 · Descaling by thermal stresses (mechanically B21, B23; chemically C23; electrolytically C25FC25F 1/00) M C21D 3/00 Diffusion processes for extraction of non-metals; Furnaces therefor (local protective coatings C21D 1/72; furnaces in general F27) M C21D 9/00 Heat treatment, e.g. annealing, hardening, quenching, or tempering, adapted for particular articles; Furnaces therefor (furnaces in general F27) M C21D 9/04 · for rails (apparatus for heat treatment of railway rails on the spot E01B 31/18) U C21D 9/08 · for tubular bodies or pipes M C21D 9/14 · · wear-resistant or pressure-resistant pipes M C21D 9/44 · for equipment for lining mine shafts, e.g.
    [Show full text]
  • In Vitro Studies of the Hepatotoxic and Hepatoprotective Potential and Metabolism of Chalcones and a Tacrine-Silibinin Codrug
    In Vitro Studies of the Hepatotoxic and Hepatoprotective Potential and Metabolism of Chalcones and a Tacrine-Silibinin Codrug Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) der Naturwissenschaftlichen Fakultät IV – Chemie und Pharmazie – der Universität Regensburg vorgelegt von Katharina Zenger aus Duggendorf 2013 Die vorliegende Arbeit wurde im Zeitraum März 2009 bis März 2013 unter Anleitung von Prof. Dr. Jörg Heilmann am Lehrstuhl Pharmazeutische Biologie der Universität Regensburg angefertigt. Das Promotionsgesuch wurde eingereicht am: 12.07.2013 Tag der mündlichen Prüfung: 30.08.2013 Prüfungsausschuss: Prof. Dr. Achim Göpferich (Vorsitzender) Prof. Dr. Jörg Heilmann (Erstgutachter) Prof. Dr. Michael Decker (Zweitgutachter) Prof. Dr. Joachim Wegener (dritter Prüfer) Für meine Eltern Ingrid und Josef Danksagung Die letzten vier Jahre waren für mich in vielerlei Hinsicht eine Herausforderung. An dieser Stelle möchte ich mich bei all den Menschen bedanken, die durch ihren Rückhalt, ihre Zuversicht und fachliche sowie persönliche Unterstützung wesentlich zum Gelingen dieser Arbeit beigetragen haben: Prof. Dr. Jörg Heilmann danke ich vielmals für die Vergabe und Betreuung des Promotionsthemas, seine stetige Unterstützung, die fachlichen Anregungen und Diskussionen und sein Vertrauen in meine Arbeitsweise. Prof. Dr. Michael Decker danke ich für die erfolgreiche Zusammenarbeit, seine hohe Einsatzbereitschaft, Unterstützung und kompetenten Ratschläge. Vielen Dank an Dr. Birgit Kraus für die wissenschaftliche Betreuung meiner Promotionsarbeit, die fachlichen Gespräche, ihre Unterstützung in allen Fragestellungen der Zellkultur und die Möglichkeit, meine Arbeit selbständig gestalten zu können. Des Weiteren möchte ich ihr für die kritische Durchsicht dieser Arbeit danken. Dr. Horst Wolff danke ich für die Einführung in die Fluoreszenzmikroskopie und Bildauswertung und seine wertvollen Hilfestellungen bezüglich aller Fragen zum Cell Observer.
    [Show full text]
  • Granny Storm Crow's MMJ Reference List- January 2011
    Granny Storm Crow's MMJ Reference List- January 2011 This is my third year of sharing "Granny's list" with all of you. Last year, I told you "How this list came about." This year, it's "Why you should be sharing my list!" From 60 pages, a symbolic celebration of my then 60 years on Earth, my list has grown to an equally symbolic 420 pages of links, in hopeful anticipation of the dawning of medical freedom in other states. My "Granny's list" contains 100s of studies about cannabis and how can heal- all done in an environment of "strong discouragement" on the part of the US government. How large my collection would be if research into this healing herb had been unrestricted? What would we know if we could have researched during those 70- odd years of prohibition? As a medicine, cannabis is potentially invaluable- this collection is ample proof of that! From stopping hiccups, to halting breast cancer's terrible spread, cannabis works! But there are still too many "may"s and "might"s when it comes to cannabis. We need more research, which will not, and cannot, happen until cannabis is legalized and rescheduled. When I began using cannabis medically over 40 years ago, there was no such thing as "medical use"- not even the concept existed! Education has made the difference. Somewhere along the line, every one of the people who have voted to legalize medical use in their state, learned that cannabis was an effective medicine, perhaps from a relative's use, or from a program they saw, or a study they read.
    [Show full text]
  • Granny Storm Crow's MMJ Reference List.Doc Jan 2010
    How this list came about- "If the truth won't do, then something is wrong!" Those were the furious words of my grandfather to my Mother. I had walked in from joyfully stuffing my face with red raspberries in the garden, straight into "war zone"! My gentle grandfather in a fury, his hand raised! Mom was just beginning to shrink back away from him. They saw me and quickly sent me away. But it was too late, the scene and the words were seared into my 5-year-old brain. That was over 55 years ago, but I still remember it clearly. My grandfather was a minister, one very short step away from God in my young mind. It was one of those life changing moments. It is still rare for me to tell a lie. I never found out what my Mother's lie was. As I child, I suffered a traumatic head injury. Another child tried to murder me with a hammer. I was left with frequent migraines. At 19, like many rebellious teens, I tried cannabis. It took about a year for me to make the connection between using cannabis and the absence of my normally frequent migraines. I have used cannabis ever since. I am an avid reader. While perusing an old book on herbal medicine, I read how the little old ladies of Mexico made and used a cannabis/tequila rub on their arthritic hands. Then I met Joey, an epileptic musician. He told me another interesting fact- when he had pot he could cut his medication in half! On a camping trip years later, I smelled an unmistakable odor.
    [Show full text]
  • AAPL 2019 Program.Indd
    AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW 50TH ANNUAL MEETING October 24-27, 2019 Baltimore, Maryland The American Academy of Psychiatry and the Law is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The American Academy of Psychiatry and the Law designates this live activity for a maximum of 31.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Fiftieth Annual Meeting American Academy of Psychiatry and the Law October 24-27, 2019 Baltimore, Maryland OFFICERS OF THE ACADEMY Richard Frierson, MD Renée Sorrentino, MD President Councilor William Newman, MD Anna Glezer, MD President-Elect Councilor Richard Martinez, MD Trent Holmberg, MD Vice President Councilor James Knoll, MD Reena Kapoor, MD Vice President Councilor Christopher R. Thompson, MD Patricia Westmoreland, MD Immediate Past President Councilor Michael Champion, MD Britta Ostermeyer, MD Secretary Councilor Stuart Anfang Karen Rosenbaum, MD Treasurer Councilor Joseph Penn, MD Hal S. Wortzel, MD Councilor Councilor PAST PRESIDENTS Christopher R. Thompson, MD 2017-18 Larry H. Strasburger, MD 2001-02 J. Richard Ciccone, MD 1986-87 Emily A. Keram, MD 2015-16 Jefrey L. Metzner, MD 2000-01 Selwyn M. Smith, MD 1985-86 Graham Glancy, MB 2014-15 Thomas G. Gutheil, MD 1999-00 Phillip J. Resnick, MD 1984-85 Robert Weinstock, MD 2013-14 Larry R. Faulkner, M.D 1998-99 Loren H. Roth, MD 1983-84 Debra Pinals, MD 2012-13 Renée L. Binder, MD 1997-98 Abraham L. Halpern, MD 1982-83 Charles Scott, MD 2011-12 Ezra E.
    [Show full text]